|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Amersham Biosciences, of Piscataway, N.J., the life sciences business of Amersham plc, introduced an addition to its CodeLink System. CodeLink UniSet Human 20K I Bioarray enables researchers to assay nearly 20,000 human genes in a single experiment using just one bioarray, it said.
o Computer Sciences Corp., of El Segundo, Calif., said DynPort Vaccine Co. LLC, a joint venture between CSC and Porton International, of London, completed Phase I testing of the safety and immunogenicity of an improved cell-cultured smallpox vaccine (CCSV). In the trial, 100 percent of 350 volunteers exhibited a positive response to either the CCSV or the historic calf lymph-produced ...
Related newspaper, magazine, and journal articles:
|
|
Article: MEGABIOS, GENEMEDICINE AGREE TO `STRATEGIC MERGER' THAT POOLS ...
BIOWORLD Today;
October 27, 1998 ;
700+ words
... ... percent, or $0.281. McGraw told BioWorld Today the move is one of the few "strategic ... into GeneMedicine," Weintraub told BioWorld Today. "This merger allows us to simplify ... up relatively early," Waldron told BioWorld Today. "This merger announcement is the ...
|
|